Two Sigma Investments
LTRN icon

Two Sigma Investments’s Lantern Pharma LTRN Stock Holding History

Two Sigma Investments’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,041
Closed -$69.8K – 4271
2025
Q3 		$69.8K Buy
+16,041
New +$67K ﹤0.01% 3511
2025
Q1 		– Sell
-16,545
Closed -$52.8K – 3377
2024
Q4 		$52.8K Sell
16,545
-17,795
-52% -$60.9K ﹤0.01% 3041
2024
Q3 		$126K Sell
34,340
-439
-1% -$1.81K ﹤0.01% 2871
2024
Q2 		$162K Buy
+34,779
New +$209K ﹤0.01% 2767
2022
Q2 		– Sell
-20,322
Closed -$145K – 2763
2022
Q1 		$145K Sell
20,322
-49,289
-71% -$329K ﹤0.01% 2384
2021
Q4 		$555K Buy
+69,611
New +$636K ﹤0.01% 3141

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Two Sigma Investments's LTRN Position: Q4 2025 in Review

Two Sigma Investments sold out of Lantern Pharma (LTRN) in Q4 2025, closing a stake of 16,041 shares — an estimated $69.8K sold.

Two Sigma Investments first reported a position in LTRN in Q4 2021 and held it in 6 quarters. The position peaked at $555K in Q4 2021. 33 funds tracked by Wall St. Rank hold LTRN as of Q4 2025.

  • Two Sigma Investments reported no remaining Lantern Pharma position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Investments sold 16,041 Lantern Pharma shares in Q4 2025, an estimated $69.8K.
  • Two Sigma Investments first reported a position in Lantern Pharma in Q4 2021 and held it in 6 quarters.
  • Two Sigma Investments's Lantern Pharma position peaked at $555K in Q4 2021.
  • 33 funds tracked by Wall St. Rank held Lantern Pharma as of Q4 2025.

Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.